These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2004486)

  • 1. Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63).
    Mendonça SC; Russell DG; Coutinho SG
    Clin Exp Immunol; 1991 Mar; 83(3):472-8. PubMed ID: 2004486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does lipophosphoglycan enhance the T cell-stimulatory activity of lipophosphoglycan-associated proteins?
    Mendonça SC; De-Luca PM; Olafson RW; Jardim A; Coutinho SG
    Braz J Med Biol Res; 1994 Feb; 27(2):553-7. PubMed ID: 8081281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi.
    Vinhas V; Freire M; Bacellar O; Cunha S; Rocha H; Carvalho EM
    Braz J Med Biol Res; 1994 May; 27(5):1199-205. PubMed ID: 8000341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins.
    Russo DM; Turco SJ; Burns JM; Reed SG
    J Immunol; 1992 Jan; 148(1):202-7. PubMed ID: 1370169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human T lymphocytes by Leishmania lipophosphoglycan.
    Kemp M; Theander TG; Handman E; Hey AS; Kurtzhals JA; Hviid L; Sørensen AL; Were JO; Koech DK; Kharazmi A
    Scand J Immunol; 1991 Feb; 33(2):219-24. PubMed ID: 1902000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway.
    Zamora-Chimal J; Fernández-Figueroa EA; Ruiz-Remigio A; Wilkins-Rodríguez AA; Delgado-Domínguez J; Salaiza-Suazo N; Gutiérrez-Kobeh L; Becker I
    Immunobiology; 2017 Feb; 222(2):454-462. PubMed ID: 27523746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-reactive gamma delta T cells in human leishmaniasis.
    Russo DM; Armitage RJ; Barral-Netto M; Barral A; Grabstein KH; Reed SG
    J Immunol; 1993 Oct; 151(7):3712-8. PubMed ID: 8376802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex.
    Jardim A; Tolson DL; Turco SJ; Pearson TW; Olafson RW
    J Immunol; 1991 Nov; 147(10):3538-44. PubMed ID: 1940354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of lipophosphoglycan-associated epitopes in different Leishmania species and in African trypanosomes.
    Tolson DL; Schnur LF; Jardim A; Pearson TW
    Parasitol Res; 1994; 80(6):537-42. PubMed ID: 7528916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major.
    Moll H; Mitchell GF; McConville MJ; Handman E
    Infect Immun; 1989 Nov; 57(11):3349-56. PubMed ID: 2807527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana.
    Bahr V; Stierhof YD; Ilg T; Demar M; Quinten M; Overath P
    Mol Biochem Parasitol; 1993 Mar; 58(1):107-21. PubMed ID: 8459823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages.
    Ibraim IC; de Assis RR; Pessoa NL; Campos MA; Melo MN; Turco SJ; Soares RP
    Parasit Vectors; 2013 Mar; 6():54. PubMed ID: 23497381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania mexicana Lipophosphoglycan Activates Dermal γδ T Cells with Participation of TLR2.
    Soto-Olguín N; Zamora-Chimal J; Delgado-Domínguez J; Becker I
    Acta Parasitol; 2023 Mar; 68(1):122-129. PubMed ID: 36434381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.
    Kurtzhals JA; Hey AS; Jardim A; Kemp M; Schaefer KU; Odera EO; Christensen CB; Githure JI; Olafson RW; Theander TG
    Clin Exp Immunol; 1994 Jun; 96(3):416-21. PubMed ID: 8004810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to Leishmania mexicana promastigote antigens. I. Secreted acid phosphatase and other proteins share epitopes with lipophosphoglycan.
    Ilg T; Menz B; Winter G; Russell DG; Etges R; Schell D; Overath P
    J Cell Sci; 1991 May; 99 ( Pt 1)():175-80. PubMed ID: 1721919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell reactivity to purified lipophosphoglycan from Leishmania major: a model for analysis of the cellular immune response to microbial carbohydrates.
    Moll H; Röllinghoff M
    Behring Inst Mitt; 1991 Feb; (88):161-9. PubMed ID: 2049034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan.
    Pinheiro RO; Pinto EF; de Matos Guedes HL; Filho OA; de Mattos KA; Saraiva EM; de Mendonça SC; Rossi-Bergmann B
    Vaccine; 2007 Mar; 25(14):2716-22. PubMed ID: 16814903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.